1.1 Key Findings: Medical Devices and Imaging Technologies

1.1 Key Findings: Medical Devices and Imaging Technologies (continued)

1.2 Selection Methodology

2.1 Unprecedented Funding and Cross-industry Collaborations spur MedTech Innovations

2.2 Snapshot of Top Technologies from our Previous Research

2.3 Shortlisting Top Technologies in a Highly Innovative Industry

2.4 Top 10 Medical Device and Imaging Technologies, 2017

3.1 Tactile Imaging Will be Driven by its Unique Ability to Quantify Tissue Health

3.2 Tactile Imaging Benefits Accurate Diagnosis of Liver Diseases and Early Breast Cancer Screening

3.3 European and Asian Companies Lead Patent Publication

3.4 Echosens and Resoundant are Championing Elastography in Different Imaging Modalities

4.1 The Need for Nanometer-level Resolution for Sub-cellular Imaging has been the Key Demand Driver

4.2 Impact of Advanced Microscopy Extends Beyond Life Sciences, into Nanotechnology and Semiconductors

4.3 IP Landscape is Dominated by Large Medical Imaging and Microscopy Companies

4.4 Zeiss, Leica, Nikon, and Canon are the Big Four Microscopy Companies

5.1 Robotic Surgery Driven by Increase in Complex Procedures that Require More Precision, Flexibility, and Control

5.2 United States is a Hot Spot for Surgical Robot Innovations

5.3 Intuitive Surgical Leads the Way With Maximum Patent Publications

5.4 High Venture Funding for Robotic Microsurgery Applications

6.1 Artificial Organ Industry Driven by Increase in Age Related Organ Functioning Disorders

6.2 Technology Adoption of Artificial Organ Rising in Europe Due to Good Government Funding

6.3 Cochlear Limited Leads the Way With Maximum Patent Applications

6.4 High Venture Capital Funding Underscores Market Urgency of Artificial Organs

7.1 Spinal Cord and Deep Brain Stimulation Witness Tremendous Adoption across the Neurostimulation Space

7.2 Technology Adoption of Artificial Organ Rising in Europe Due to Good Government Funding

7.3 Medtronic Leads IP Activity in the Neurostimulation Market

7.4 Expansion to New Clinical Indications Generates Interest Amongst Investors

8.1 3D Medical Imaging is Designed to Improve Imaging and Viewing Through 2D Imaging Platforms

8.2 3D visualization Will Enable Better Diagnostic Visualization, Surgical Planning

8.3 3D Medical Imaging Will be an Invaluable Tool for Advanced Surgical Planning and Early Stage Diagnosis of Various Disorders

8.4 Sustained Private Venture Capital Funding Bolsters Imaging Innovation

9.1 X-eluting Stents Capitalizing on the Decline in Bare-metal Stent Market Share

9.2 Incorporation of Biological Agents Enhance Clinical Safety and Effectiveness of X-eluting Stents

9.3 Sustained IP Filing Indicates Vibrant R&D Activity in XES Market

9.4 Hydrogel-based 4D Printing of Stents that Change Shape Upon Exposure to Heat Gain Attention from Investors

10.1 Proton Beam Therapy is designed to be a specific source of treatment for various forms of cancers

10.2 Market Growth for Proton Beam Therapies in Europe Exceeds that of North America

10.3 Proton Beam Therapy will be an Invaluable Tool for Targeting Cancerous Tissues

10.4 Image-guidance and Surgical Planning Tools will Help Minimize Dosage, Maximize Efficacy

11.1 Smart Bandages are Designed with Sense-and-treat Capabilities to Address Challenges in Treating Hard-to-heal Wounds

11.2 Demand for Easily Accessible and Easy to Use Wound Care Products are Expected to Drive Market Growth

11.3 Smart Bandages Will be an Invaluable Tool for Advanced Wound Care in Early Stage Diagnosis

11.4 Wound Care Innovation is Supported by Public Funding Agencies, Defense and Military Budgets

12.1 Real-time Information through Optical Biopsy Reduces Delay in Diagnosis to Treatment

12.2 North America to Remain the Strongest Adopter of Optical Biopsy

12.3 Optical Biopsy to Aid in Confocal Light Endomicroscopy for Detecting Tissue Abnormality

12.4 Optical Biopsy for Colorectal and Prostate Cancer Expected to Witness Demand

13.1 The Frost & Sullivan Story

13.2 Value Proposition: Future of Your Company & Career

13.3 Global Perspective

13.4 Industry Convergence

13.5 360º Research Perspective

13.6 Implementation Excellence

13.7 Our Blue Ocean Strategy